175 related articles for article (PubMed ID: 10674878)
1. Mammaglobin B as a novel marker for detection of breast cancer micrometastases in axillary lymph nodes by reverse transcription-polymerase chain reaction.
Aihara T; Fujiwara Y; Ooka M; Sakita I; Tamaki Y; Monden M
Breast Cancer Res Treat; 1999 Nov; 58(2):137-40. PubMed ID: 10674878
[TBL] [Abstract][Full Text] [Related]
2. Mammaglobin B gene as a novel marker for lymph node micrometastasis in patients with abdominal cancers.
Aihara T; Fujiwara Y; Miyake Y; Okami J; Okada Y; Iwao K; Sugita Y; Tomita N; Sakon M; Shiozaki H; Monden M
Cancer Lett; 2000 Mar; 150(1):79-84. PubMed ID: 10755390
[TBL] [Abstract][Full Text] [Related]
3. Combining mammaglobin and carcinoembryonic mRNA markers for early detection of micrometastases from breast cancers--a molecular study of 59 patients.
Ghaffari SR; Sabokbar T; Tahmasebi S; Dastan J; Shorakae S; Moradi A; Tirgari F; Mohagheghi MA; Mosavi-Jarrahi A
Asian Pac J Cancer Prev; 2006; 7(3):396-8. PubMed ID: 17059329
[TBL] [Abstract][Full Text] [Related]
4. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction.
Noguchi S; Aihara T; Nakamori S; Motomura K; Inaji H; Imaoka S; Koyama H
Cancer; 1994 Sep; 74(5):1595-600. PubMed ID: 7520351
[TBL] [Abstract][Full Text] [Related]
5. RT-PCR for mammaglobin genes, MGB1 and MGB2, identifies breast cancer micrometastases in sentinel lymph nodes.
Ouellette RJ; Richard D; Maïcas E
Am J Clin Pathol; 2004 May; 121(5):637-43. PubMed ID: 15151203
[TBL] [Abstract][Full Text] [Related]
6. mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients.
Marchetti A; Buttitta F; Bertacca G; Zavaglia K; Bevilacqua G; Angelucci D; Viacava P; Naccarato A; Bonadio A; Barassi F; Felicioni L; Salvatore S; Mucilli F
J Pathol; 2001 Sep; 195(2):186-90. PubMed ID: 11592097
[TBL] [Abstract][Full Text] [Related]
7. Genetic detection for micrometastasis in lymph node of biliary tract carcinoma.
Okami J; Dohno K; Sakon M; Iwao K; Yamada T; Yamamoto H; Fujiwara Y; Nagano H; Umeshita K; Matsuura N; Nakamori S; Monden M
Clin Cancer Res; 2000 Jun; 6(6):2326-32. PubMed ID: 10873083
[TBL] [Abstract][Full Text] [Related]
8. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUC1 mRNA and keratin 19 mRNA amplification.
Noguchi S; Aihara T; Motomura K; Inaji H; Imaoka S; Koyama H
Am J Pathol; 1996 Feb; 148(2):649-56. PubMed ID: 8579127
[TBL] [Abstract][Full Text] [Related]
9. Detection of micrometastases in lymph nodes from patients with breast cancer.
Branagan G; Hughes D; Jeffrey M; Crane-Robinson C; Perry PM
Br J Surg; 2002 Jan; 89(1):86-9. PubMed ID: 11851670
[TBL] [Abstract][Full Text] [Related]
10. [The detection of breast carcinoma micrometastases in axillary lymph nodes by reverse transcriptase-polymerase chain reaction].
Zhang Q; Zhang Y; Gu X; Zhang M; Lin H; Qian H
Zhonghua Wai Ke Za Zhi; 1998 Jul; 36(7):430-2. PubMed ID: 11825433
[TBL] [Abstract][Full Text] [Related]
11. Mammaglobin, a potential marker of breast cancer nodal metastasis.
Leygue E; Snell L; Dotzlaw H; Hole K; Troup S; Hiller-Hitchcock T; Murphy LC; Watson PH
J Pathol; 1999 Sep; 189(1):28-33. PubMed ID: 10451484
[TBL] [Abstract][Full Text] [Related]
12. Mammaglobin expression in lymph nodes is an important marker of metastatic breast carcinoma.
Han JH; Kang Y; Shin HC; Kim HS; Kang YM; Kim YB; Oh SY
Arch Pathol Lab Med; 2003 Oct; 127(10):1330-4. PubMed ID: 14521461
[TBL] [Abstract][Full Text] [Related]
13. Plasma mammaglobin messenger RNA in breast cancer patients as an addition to serum tumor.
El-Attar NI; Gaefar HA
Egypt J Immunol; 2007; 14(2):111-21. PubMed ID: 20306663
[TBL] [Abstract][Full Text] [Related]
14. [Detection of breast cancer micrometastases in lymph nodes by amplification of keratin 19 mRNA with reverse-transcriptase polymerase chain reaction].
Noguchi S; Aihara T; Motomura K; Inaji H; Koyama H
Gan To Kagaku Ryoho; 1996 Mar; 23 Suppl 1():50-5. PubMed ID: 8702311
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of an extensive histopathologic examination and a real-time reverse-transcription-polymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patients.
Viale G; Dell'Orto P; Biasi MO; Stufano V; De Brito Lima LN; Paganelli G; Maisonneuve P; Vargo JM; Green G; Cao W; Swijter A; Mazzarol G
Ann Surg; 2008 Jan; 247(1):136-42. PubMed ID: 18156933
[TBL] [Abstract][Full Text] [Related]
16. Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies.
Zafrakas M; Petschke B; Donner A; Fritzsche F; Kristiansen G; Knüchel R; Dahl E
BMC Cancer; 2006 Apr; 6():88. PubMed ID: 16603086
[TBL] [Abstract][Full Text] [Related]
17. Detection of occult breast cancer micrometastases in axillary lymph nodes using a multimarker reverse transcriptase-polymerase chain reaction panel.
Lockett MA; Baron PL; O'Brien PH; Elliott BM; Robison JG; Maitre N; Metcalf JS; Cole DJ
J Am Coll Surg; 1998 Jul; 187(1):9-16. PubMed ID: 9660019
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of three mRNA markers for the detection of lymph node metastases.
Berger J; Mueller-Holzner E; Fiegl H; Marth C; Daxenbichler G
Anticancer Res; 2006; 26(5B):3855-60. PubMed ID: 17094413
[TBL] [Abstract][Full Text] [Related]
19. Mammaglobin expression in primary, metastatic, and occult breast cancer.
Watson MA; Dintzis S; Darrow CM; Voss LE; DiPersio J; Jensen R; Fleming TP
Cancer Res; 1999 Jul; 59(13):3028-31. PubMed ID: 10397237
[TBL] [Abstract][Full Text] [Related]
20. Mammaglobin and lipophilin B expression in breast tumors and their lack of effect on breast cancer cell proliferation.
Sjödin A; Ljuslinder I; Henriksson R; Hedman H
Anticancer Res; 2008; 28(3A):1493-8. PubMed ID: 18630503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
